(Q53394507)

13 May 2018

title

Will anti-amyloid therapies work for Alzheimer's disease? (English)

1 reference

13 May 2018

Peter Henry St George-Hyslop

main subject

Alzheimer's disease

0 references

author

series ordinal

1

1 reference

13 May 2018

John C. Morris

series ordinal

2

object named as

John C Morris

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 July 2008

1 reference

13 May 2018

number of pages

3

1 reference

inferred from page(s)

published in

The Lancet

1 reference

13 May 2018

volume

372

1 reference

13 May 2018

issue

9634

1 reference

13 May 2018

page(s)

180-182

1 reference

13 May 2018

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961047-8

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961047-8

7 January 2021

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961047-8

7 January 2021

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961047-8

7 January 2021

A beta oligomers - a decade of discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961047-8

7 January 2021

Abeta-42 deposition precedes other changes in PS-1 Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961047-8

7 January 2021

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961047-8

7 January 2021

Genetic complexity of Alzheimer's disease: successes and challenges.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961047-8

7 January 2021

Genetic and host factors for dementia in Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961047-8

7 January 2021

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961047-8

7 January 2021

Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961047-8

7 January 2021

Tau suppression in a neurodegenerative mouse model improves memory function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961047-8

7 January 2021

Neuronal damage in brain inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961047-8

7 January 2021

10.1016/S0140-6736(08)61047-8

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018